- Home
- Publications
- Publication Search
- Publication Details
Title
Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics
Authors
Keywords
-
Journal
Biomedicines
Volume 10, Issue 9, Pages 2179
Publisher
MDPI AG
Online
2022-09-06
DOI
10.3390/biomedicines10092179
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics
- (2022) Sean C. Semple et al. Pharmaceutics
- Inhaled delivery of a lipid nanoparticle encapsulated messenger RNA encoding a ciliary protein for the treatment of primary ciliary dyskinesia
- (2022) Caroline J. Woo et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Aerosolizable siRNA-Encapsulated Solid Lipid Nanoparticles Prepared by Thin-film Freeze-Drying for Potential Pulmonary Delivery
- (2021) Jie-Liang Wang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines
- (2021) S. Moein Moghimi MOLECULAR THERAPY
- Invited review: The role of allergen‐specific IgE, IgG and IgA in allergic disease
- (2021) Mohamed H. Shamji et al. ALLERGY
- Drug metabolism in the lungs: opportunities for optimising inhaled medicines
- (2021) Zachary Enlo-Scott et al. Expert Opinion on Drug Metabolism & Toxicology
- Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
- (2021) Thai Thanh Hoang Thi et al. Vaccines
- Lipid Nanoparticles—From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement
- (2021) Rumiana Tenchov et al. ACS Nano
- Oral inhalation for delivery of proteins and peptides to the lungs
- (2021) Eleonore Fröhlich et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
- (2021) Shengguang Wang et al. Frontiers in Pharmacology
- Lipid nanoparticles for mRNA delivery
- (2021) Xucheng Hou et al. Nature Reviews Materials
- Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines
- (2021) Yi Guo et al. Acta Pharmaceutica Sinica B
- The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application
- (2021) Jun Wu Journal of Personalized Medicine
- Preparation of Curcumin Solid Lipid Nanoparticles Loaded with Flower-Shaped Lactose for Lung Inhalation and Preliminary Evaluation of Cytotoxicity In Vitro
- (2021) Nan Li et al. Evidence-based Complementary and Alternative Medicine
- Silibinin loaded inhalable solid lipid nanoparticles for lung targeting
- (2021) Priya Patel et al. JOURNAL OF MICROENCAPSULATION
- Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12–18 Years in Saudi Arabia
- (2021) Edrous Alamer et al. Vaccines
- Antibodies against polyethylene glycol in human blood: A literature review
- (2020) Lu Hong et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Severe Acute Lung Injury Related to COVID‐19 Infection: A Review and the Possible Role for Escin
- (2020) Luca Gallelli et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Promoted Antitumor Activity of Myricetin against Lung Carcinoma Via Nanoencapsulated Phospholipid Complex in Respirable Microparticles
- (2020) Noha Nafee et al. PHARMACEUTICAL RESEARCH
- In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment?
- (2020) Eleonora Truzzi et al. Nanomaterials
- Lipid nanoparticles for nucleic acid delivery: Current perspectives
- (2020) Eleni Samaridou et al. ADVANCED DRUG DELIVERY REVIEWS
- Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
- (2020) Gergely Tibor Kozma et al. ADVANCED DRUG DELIVERY REVIEWS
- Preparation and evaluation of inhalable dry powder containing glucosamine-conjugated gefitinib SLNs for lung cancer therapy
- (2020) Nazafarin Satari et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Changes in respiratory symptoms during 48 weeks treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies
- (2020) James D Chalmers et al. EUROPEAN RESPIRATORY JOURNAL
- Deposition Mechanisms
- (2020) Chantal Darquenne Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Peptides as surface coatings of nanoparticles that penetrate human cystic fibrosis sputum and uniformly distribute in vivo following pulmonary delivery
- (2020) Jasmim Leal et al. JOURNAL OF CONTROLLED RELEASE
- COVID ‐19 acute respiratory distress syndrome ( ARDS ): clinical features and differences from typical pre‐ COVID ‐19 ARDS
- (2020) Peter G Gibson et al. MEDICAL JOURNAL OF AUSTRALIA
- The Use of Amikacin Liposome Inhalation Suspension (Arikayce) in the Treatment of Refractory Nontuberculous Mycobacterial Lung Disease in Adults
- (2020) Omer Khan et al. Drug Design Development and Therapy
- Inhaled Corticosteroids and Endocrine Effects in Childhood
- (2020) David B. Allen ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Nucleic acid therapeutics: a focus on the development of aptamers
- (2020) Swati Jain et al. Expert Opinion on Drug Discovery
- Inhaled nanoparticles–An updated review
- (2020) Tuangrat Praphawatvet et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment
- (2020) Anant Parasher POSTGRADUATE MEDICAL JOURNAL
- A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers
- (2020) Ruhisy Mohd Rasul et al. CARBOHYDRATE POLYMERS
- Enhancing nanoparticle penetration through airway mucus to improve drug delivery efficacy in the lung
- (2020) Daiqin Chen et al. Expert Opinion on Drug Delivery
- Engineering precision nanoparticles for drug delivery
- (2020) Michael J. Mitchell et al. NATURE REVIEWS DRUG DISCOVERY
- Inhalation treatment of cystic fibrosis with lumacaftor and ivacaftor co-delivered by nanostructured lipid carriers
- (2019) O.B. Garbuzenko et al. JOURNAL OF CONTROLLED RELEASE
- Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials
- (2019) Charles S Haworth et al. Lancet Respiratory Medicine
- Enhanced antitubercular activity, alveolar deposition and macrophages uptake of mannosylated stable nanoliposomes
- (2019) Amira Hamed et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Nanoparticles for Nucleic Acid Delivery: Applications in Cancer Immunotherapy
- (2019) Alvin J. Mukalel et al. CANCER LETTERS
- Oral delivery of non-viral nucleic acid-based therapeutics - do we have the guts for this?
- (2019) Caitriona M. O'Driscoll et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
- (2019) Robert A. Feldman et al. VACCINE
- Pharmacogenetic Factors Affecting Asthma Treatment Response. Potential Implications for Drug Therapy
- (2019) Jesús Miguel García-Menaya et al. Frontiers in Pharmacology
- Ciprofloxacin nanocrystals liposomal powders for controlled drug release via inhalation
- (2019) Isra Khatib et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Cytotoxicity screening of emulsifiers for pulmonary application of lipid nanoparticles
- (2019) Verena Steiner et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Xenobiotica-metabolizing enzymes in the lung of experimental animals, man and in human lung models
- (2019) F. Oesch et al. ARCHIVES OF TOXICOLOGY
- Tissue‐resident innate immunity in the lung
- (2019) Amanda Ardain et al. IMMUNOLOGY
- Development of chitosan-coated liposome for pulmonary delivery of N-acetylcysteine
- (2019) Hamed Hamedinasab et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Hybrid Ofloxacin/eugenol co-loaded solid lipid nanoparticles with enhanced and targetable antimicrobial properties
- (2019) B. Rodenak-Kladniew et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Effects of the solid lipid nanoparticle of carvacrol on rodents with lung injury from smoke inhalation
- (2019) Fernanda O. Carvalho et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases
- (2019) Caleb F. Anderson et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!
- (2019) Thomas Sécher et al. Frontiers in Immunology
- Inhaled rapamycin solid lipid nano particles for the treatment of Lymphangioleiomyomatosis
- (2019) Emelie Landh et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Pharmacology and Therapeutics of Bronchodilators Revisited
- (2019) M. G. Matera et al. PHARMACOLOGICAL REVIEWS
- PEGylation for enhancing nanoparticle diffusion in mucus
- (2018) Justin T. Huckaby et al. ADVANCED DRUG DELIVERY REVIEWS
- Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes
- (2018) Jens Markus Borghardt et al. Canadian Respiratory Journal
- Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide
- (2018) Congcong Lin et al. DRUG DELIVERY
- Mucus-penetrating solid lipid nanoparticles for the treatment of cystic fibrosis: Proof of concept, challenges and pitfalls
- (2018) N. Nafee et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
- (2018) Anthony De Soyza et al. EUROPEAN RESPIRATORY JOURNAL
- RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
- (2018) Timothy Aksamit et al. EUROPEAN RESPIRATORY JOURNAL
- Preparation of drug-loaded small unilamellar liposomes and evaluation of their potential for the treatment of chronic respiratory diseases
- (2018) Vincenzo De Leo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates
- (2018) Hadeer M. Abdelaziz et al. JOURNAL OF CONTROLLED RELEASE
- New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation
- (2018) Rémi Rosière et al. MOLECULAR PHARMACEUTICS
- Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis
- (2018) Ema Robinson et al. MOLECULAR THERAPY
- Inhaled hexadecyl-treprostinil provides pulmonary vasodilator activity at significantly lower plasma concentrations than infused treprostinil
- (2018) Richard W. Chapman et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseases
- (2018) Gary T. Ferguson et al. RESPIRATORY MEDICINE
- Effective silencing of ENaC by siRNA delivered with epithelial-targeted nanocomplexes in human cystic fibrosis cells and in mouse lung
- (2018) Aristides D Tagalakis et al. THORAX
- Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages
- (2018) Jimin Zhang et al. Frontiers in Microbiology
- Inhaled corticosteroids in COPD: Friend or foe?
- (2018) Alvar Agusti et al. EUROPEAN RESPIRATORY JOURNAL
- Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract
- (2018) Rebecca L. Ball et al. Scientific Reports
- Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
- (2018) Donald P Tashkin et al. International Journal of Chronic Obstructive Pulmonary Disease
- Nanostructured lipid carriers versus solid lipid nanoparticles for the potential treatment of pulmonary hypertension via nebulization
- (2018) Noha Nafee et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Lung Homeostasis: Influence of Age, Microbes, and the Immune System
- (2017) Clare M. Lloyd et al. IMMUNITY
- Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α- d -mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy
- (2017) Eleonora Maretti et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Lipid Nanoparticle Systems for Enabling Gene Therapies
- (2017) Pieter R. Cullis et al. MOLECULAR THERAPY
- PEGylation of paclitaxel largely improves its safety and anti-tumor efficacy following pulmonary delivery in a mouse model of lung carcinoma
- (2016) Tian Luo et al. JOURNAL OF CONTROLLED RELEASE
- Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications
- (2016) Mindaugas Rudokas et al. MEDICAL PRINCIPLES AND PRACTICE
- The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?
- (2016) Christian Lubich et al. PHARMACEUTICAL RESEARCH
- Lipid Nanoparticle Delivery of siRNA to Osteocytes Leads to Effective Silencing of SOST and Inhibition of Sclerostin In Vivo
- (2016) Genc Basha et al. Molecular Therapy-Nucleic Acids
- Long-acting β2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety
- (2016) Andrea Rossi International Journal of Chronic Obstructive Pulmonary Disease
- Recent advances in controlled pulmonary drug delivery
- (2015) Zhenglin Liang et al. DRUG DISCOVERY TODAY
- Nebulization as a delivery method for mAbs in respiratory diseases
- (2015) Renaud Respaud et al. Expert Opinion on Drug Delivery
- The mucosal immune system: From dentistry to vaccine development
- (2015) Hiroshi KIYONO et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Aerosolized Medications for Gene and Peptide Therapy
- (2015) B. L. Laube Respiratory Care
- Nanocarrier for Poorly Water-Soluble Anticancer Drugs—Barriers of Translation and Solutions
- (2014) Mayuri Narvekar et al. AAPS PHARMSCITECH
- The use of natural and synthetic phospholipids as pharmaceutical excipients
- (2014) Peter van Hoogevest et al. EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY
- Redispersible liposomal-N-acetylcysteine powder for pulmonary administration: Development, in vitro characterization and antioxidant activity
- (2014) Aline Ferreira Ourique et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Nanoparticle-Mediated Pulmonary Drug Delivery: A Review
- (2014) Mukta Paranjpe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- New anti-inflammatory targets for chronic obstructive pulmonary disease
- (2013) Peter J. Barnes NATURE REVIEWS DRUG DISCOVERY
- Liposome: classification, preparation, and applications
- (2013) Abolfazl Akbarzadeh et al. Nanoscale Research Letters
- Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the Brain
- (2013) Ravi L Rungta et al. Molecular Therapy-Nucleic Acids
- Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
- (2012) Anu Puri et al. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Muscarinic Receptors and Their Antagonists in COPD: Anti-Inflammatory and Antiremodeling Effects
- (2012) George Karakiulakis et al. MEDIATORS OF INFLAMMATION
- Pulmonary delivery of elcatonin using surface-modified liposomes to improve systemic absorption: Polyvinyl alcohol with a hydrophobic anchor and chitosan oligosaccharide as effective surface modifiers
- (2011) Mitsutaka Murata et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Development of an Inhaled Dry-Powder Formulation of Tobramycin Using PulmoSphere™ Technology
- (2011) David E. Geller et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells
- (2011) Genc Basha et al. MOLECULAR THERAPY
- A Dry Powder Formulation of Liposome-Encapsulated Recombinant Secretory Leukocyte Protease Inhibitor (rSLPI) for Inhalation: Preparation and Characterisation
- (2010) Aileen Gibbons et al. AAPS PHARMSCITECH
- Adaptive immunity
- (2010) Francisco A. Bonilla et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Structure and function of immunoglobulins
- (2010) Harry W. Schroeder et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Absorption of Calcitonin in Oral and Pulmonary Administration with Polymer-coated Liposomes
- (2010) Hirofumi TAKEUCHI et al. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
- Impact of Nanotechnology on Drug Delivery
- (2009) Omid C. Farokhzad et al. ACS Nano
- Solid Lipid Nanoparticles as Insulin Inhalation Carriers for Enhanced Pulmonary Delivery
- (2009) Ru Bi et al. Journal of Biomedical Nanotechnology
- [186Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model
- (2009) Anuradha Soundararajan et al. NUCLEAR MEDICINE AND BIOLOGY
- Solid lipid nanoparticles for pulmonary delivery of insulin
- (2008) Jie Liu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Inhalable liposomal formulation for vasoactive intestinal peptide
- (2008) Franz Hajos et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search